SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-19-011219
Filing Date
2019-11-26
Accepted
2019-11-26 16:45:43
Documents
12
Period of Report
2019-11-20
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K imgn-20191120x8kcdcf465.htm   iXBRL 8-K 32473
  Complete submission text file 0001558370-19-011219.txt   150107

Data Files

Seq Description Document Type Size
2 EX-101.SCH imgn-20191120.xsd EX-101.SCH 3267
3 EX-101.LAB imgn-20191120_lab.xml EX-101.LAB 15501
4 EX-101.PRE imgn-20191120_pre.xml EX-101.PRE 10512
11 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20191120x8kcdcf465_htm.xml XML 4692
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 191251654
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences